<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35120624</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-6711</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>Stem cell reports</Title><ISOAbbreviation>Stem Cell Reports</ISOAbbreviation></Journal><ArticleTitle>Homozygous ALS-linked FUS P525L mutations cell- autonomously perturb transcriptome profile and chemoreceptor signaling in human iPSC microglia.</ArticleTitle><Pagination><StartPage>678</StartPage><EndPage>692</EndPage><MedlinePgn>678-692</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.stemcr.2022.01.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-6711(22)00048-0</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is a fatal disease pathologically typified by motor and cortical neurodegeneration as well as microgliosis. The FUS P525L mutation is highly penetrant and causes ALS cases with earlier disease onset and more aggressive progression. To date, how P525L mutations may affect microglia during ALS pathogenesis had not been explored. In this study, we engineered isogenic control and P525L mutant FUS in independent human iPSC lines and differentiated them into microglia-like cells. We report that the P525L mutation causes FUS protein to mislocalize from the nucleus to cytoplasm. Homozygous P525L mutations perturb the transcriptome profile in which many differentially expressed genes are associated with microglial functions. Specifically, the dysregulation of several chemoreceptor genes leads to altered chemoreceptor-activated calcium signaling. However, other microglial functions such as phagocytosis and cytokine release are not significantly affected. Our study underscores the cell-autonomous effects of the ALS-linked FUS P525L mutation in a human microglia model.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kerk</LastName><ForeName>Sze Yen</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA. Electronic address: john.kerk@regeneron.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Janell</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalgudi</LastName><ForeName>Pranav</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunt</LastName><ForeName>Charleen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuno</LastName><ForeName>Junko</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nuara</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanza</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Newton</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppola</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espert</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Henderson</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fannell</LastName><ForeName>Casey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zambrowicz</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiao</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA. Electronic address: eric.chiao@regeneron.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stem Cell Reports</MedlineTA><NlmUniqueID>101611300</NlmUniqueID><ISSNLinking>2213-6711</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="Y">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">chemoreceptor signaling</Keyword><Keyword MajorTopicYN="N">human iPSC</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">transcriptome profile</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>5</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35120624</ArticleId><ArticleId IdType="pmc">PMC9039753</ArticleId><ArticleId IdType="doi">10.1016/j.stemcr.2022.01.004</ArticleId><ArticleId IdType="pii">S2213-6711(22)00048-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abud E.M., Ramirez R.N., Martinez E.S., Healy L.M., Nguyen C.H.H., Newman S.A., Yeromin A.V., Scarfone V.M., Marsh S.E., Fimbres C., et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron. 2017;94:278&#x2013;293.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5482419</ArticleId><ArticleId IdType="pubmed">28426964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmone-Cat M.A., Onori A., Toselli C., Stronati E., Morlando M., Bozzoni I., Monni E., Kokaia Z., Lupo G., Minghetti L., et al. Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci. Rep. 2019;9:4572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6418113</ArticleId><ArticleId IdType="pubmed">30872738</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwar S., Pons V., Rivest S. Microglia purinoceptor P2Y6: an emerging therapeutic target in CNS diseases. Cells. 2020;9:1595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7407337</ArticleId><ArticleId IdType="pubmed">32630251</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M.L., Bennett F.C., Liddelow S.A., Ajami B., Zamanian J.L., Fernhoff N.B., Mulinyawe S.B., Bohlen C.J., Adil A., Tucker A., et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl. Acad. Sci. U S A. 2016;113:E1738&#x2013;E1746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4812770</ArticleId><ArticleId IdType="pubmed">26884166</ArticleId></ArticleIdList></Reference><Reference><Citation>Berjaoui S., Povedano M., Garcia-Esparcia P., Carmona M., Aso E., Ferrer I. Complex inflammation mRNA-related response in ALS is region dependent. Neural Plast. 2015;2015:573784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4537753</ArticleId><ArticleId IdType="pubmed">26301107</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Jedrychowski M.P., Moore C.S., Cialic R., Lanser A.J., Gabriely G., Koeglsperger T., Dake B., Wu P.M., Doykan C.E., et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci. 2014;17:131&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke B.E., Patani R. The microglial component of amyotrophic lateral sclerosis. Brain. 2020;143:3526&#x2013;3539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805793</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId></ArticleIdList></Reference><Reference><Citation>Consilvio C., Vincent A.M., Feldman E.L. Neuroinflammation, COX-2, and ALS--a dual role? Exp. Neurol. 2004;187:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">15081582</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox M.A., Gomes B., Palmer K., Du K., Wiekowski M., Wilburn B., Petro M., Chou C.C., Desquitado C., Schwarz M., et al. The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. Biochem. Biophys. Res. Commun. 2005;330:467&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">15796906</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ambrosi N., Finocchi P., Apolloni S., Cozzolino M., Ferri A., Padovano V., Pietrini G., Carri M.T., Volonte C. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J.&#xa0;Immunol. 2009;183:4648&#x2013;4656.</Citation><ArticleIdList><ArticleId IdType="pubmed">19734218</ArticleId></ArticleIdList></Reference><Reference><Citation>Douvaras P., Sun B., Wang M., Kruglikov I., Lallos G., Zimmer M., Terrenoire C., Zhang B., Gandy S., Schadt E., et al. Directed differentiation of human pluripotent stem cells to microglia. Stem Cell Rep. 2017;8:1516&#x2013;1524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5470097</ArticleId><ArticleId IdType="pubmed">28528700</ArticleId></ArticleIdList></Reference><Reference><Citation>Errichelli L., Dini Modigliani S., Laneve P., Colantoni A., Legnini I., Capauto D., Rosa A., De Santis R., Scarfo R., Peruzzi G., et al. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat Commun. 2017;8:14741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5379105</ArticleId><ArticleId IdType="pubmed">28358055</ArticleId></ArticleIdList></Reference><Reference><Citation>Funikov S.Y., Rezvykh A.P., Mazin P.V., Morozov A.V., Maltsev A.V., Chicheva M.M., Vikhareva E.A., Evgen'ev M.B., Ustyugov A.A. FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy. Neurogenetics. 2018;19:189&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">29982879</ArticleId></ArticleIdList></Reference><Reference><Citation>Galatro T.F., Holtman I.R., Lerario A.M., Vainchtein I.D., Brouwer N., Sola P.R., Veras M.M., Pereira T.F., Leite R.E.P., Moller T., et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. Nat. Neurosci. 2017;20:1162&#x2013;1171.</Citation><ArticleIdList><ArticleId IdType="pubmed">28671693</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia R.A., Yan M., Search D., Zhang R., Carson N.L., Ryan C.S., Smith-Monroy C., Zheng J., Chen J., Kong Y., et al. P2Y6 receptor potentiates pro-inflammatory responses in macrophages and exhibits differential roles in atherosclerotic lesion development. PLoS One. 2014;9:e111385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4216081</ArticleId><ArticleId IdType="pubmed">25360548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginhoux F., Lim S., Hoeffel G., Low D., Huber T. Origin and differentiation of microglia. Front Cell Neurosci. 2013;7:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3627983</ArticleId><ArticleId IdType="pubmed">23616747</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin D., Skola D., Coufal N.G., Holtman I.R., Schlachetzki J.C.M., Sajti E., Jaeger B.N., O&#x2019;Connor C., Fitzpatrick C., Pasillas M.P., et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356:eaal3222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5858585</ArticleId><ArticleId IdType="pubmed">28546318</ArticleId></ArticleIdList></Reference><Reference><Citation>Green D.R., Oguin T.H., Martinez J. The clearance of dying cells: table for two. Cell Death Differ. 2016;23:915&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987729</ArticleId><ArticleId IdType="pubmed">26990661</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Naujock M., Fumagalli L., Vandoorne T., Baatsen P., Boon R., Ordovas L., Patel A., Welters M., Vanwelden T., et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 2017;8:861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman S., Izzy S., Sen P., Morsett L., El Khoury J. Microglia in neurodegeneration. Nat. Neurosci. 2018;21:1359&#x2013;1369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6817969</ArticleId><ArticleId IdType="pubmed">30258234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman S.E., Kingery N.D., Ohsumi T.K., Borowsky M.L., Wang L.C., Means T.K., El Khoury J. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 2013;16:1896&#x2013;1905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3840123</ArticleId><ArticleId IdType="pubmed">24162652</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks G.G., Singh N., Nashabi A., Mai S., Bozek G., Klewes L., Arapovic D., White E.K., Koury M.J., Oltz E.M., et al. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat. Genet. 2000;24:175&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji A.L., Zhang X., Chen W.W., Huang W.J. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum. J.&#xa0;Med. Genet. 2017;54:145&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">28087719</ArticleId></ArticleIdList></Reference><Reference><Citation>Johann S., Heitzer M., Kanagaratnam M., Goswami A., Rizo T., Weis J., Troost D., Beyer C. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia. 2015;63:2260&#x2013;2273.</Citation><ArticleIdList><ArticleId IdType="pubmed">26200799</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Banno H., Suzuki K., Tanaka F., Sobue G. Transforming growth factor-beta signaling in motor neuron diseases. Curr. Mol. Med. 2011;11:48&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">21189118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B., Jeong H.K., Kim J.H., Lee S.Y., Jou I., Joe E.H. Uridine 5'-diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptor. J.&#xa0;Immunol. 2011;186:3701&#x2013;3709.</Citation><ArticleIdList><ArticleId IdType="pubmed">21317391</ArticleId></ArticleIdList></Reference><Reference><Citation>Klejbor I., Shimshek D.R., Klimaszewska-Lata J., Velasco-Estevez M., Morys J., Karaszewski B., Szutowicz A., Rutkowska A. EBI2 is expressed in glial cells in multiple sclerosis lesions, and its knock-out modulates remyelination in the cuprizone model. Eur. J. Neurosci. 2021;54:5173&#x2013;5188.</Citation><ArticleIdList><ArticleId IdType="pubmed">34145920</ArticleId></ArticleIdList></Reference><Reference><Citation>Koizumi S., Shigemoto-Mogami Y., Nasu-Tada K., Shinozaki Y., Ohsawa K., Tsuda M., Joshi B.V., Jacobson K.A., Kohsaka S., Inoue K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature. 2007;446:1091&#x2013;1095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3464483</ArticleId><ArticleId IdType="pubmed">17410128</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang L., Kamelgarn M., Arenas A., Gal J., Taylor D., Gong W., Brown M., St Clair D., Kasarskis E.J., Zhu H. Clinical and experimental studies of a novel P525R FUS mutation in amyotrophic lateral sclerosis. Neurol. Genet. 2017;3:e172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5546284</ArticleId><ArticleId IdType="pubmed">28812062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurschus F.C., Wanke F. EBI2 - sensor for dihydroxycholesterol gradients in neuroinflammation. Biochimie. 2018;153:52&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">29689289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavin Y., Winter D., Blecher-Gonen R., David E., Keren-Shaul H., Merad M., Jung S., Amit I. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell. 2014;159:1312&#x2013;1326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437213</ArticleId><ArticleId IdType="pubmed">25480296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Appleton K.M., El-Shewy H.M., Sorci-Thomas M.G., Thomas M.J., Lopes-Virella M.F., Luttrell L.M., Hammad S.M., Klein R.L. S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization. J.&#xa0;Lipid Res. 2017;58:325&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5282949</ArticleId><ArticleId IdType="pubmed">27881715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi J., De Santis R., de Turris V., Morlando M., Laneve P., Calvo A., Caliendo V., Chio A., Rosa A., Bozzoni I. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons. Dis. Model Mech. 2015;8:755&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486861</ArticleId><ArticleId IdType="pubmed">26035390</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Barres B.A. Microglia and macrophages in brain homeostasis and disease. Nat. Rev. Immunol. 2018;18:225&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">29151590</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao F., Shirakawa A.K., Foley J.F., Rabin R.L., Farber J.M. Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J.&#xa0;Immunol. 2002;168:4871&#x2013;4880.</Citation><ArticleIdList><ArticleId IdType="pubmed">11994436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Bello M., Di Fini F., Notaro A., Spataro R., Conforti F.L., La Bella V. ALS-related mutant FUS protein is mislocalized to cytoplasm and is recruited into stress granules of fibroblasts from asymptomatic FUS P525L mutation carriers. Neurodegener Dis. 2017;17:292&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">29035885</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyashchenko A.K. Columbia University; 2015. Mechanisms of FUS-Mediated Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis.</Citation></Reference><Reference><Citation>Mitchell J.C., McGoldrick P., Vance C., Hortobagyi T., Sreedharan J., Rogelj B., Tudor E.L., Smith B.N., Klasen C., Miller C.C., et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Muffat J., Li Y., Yuan B., Mitalipova M., Omer A., Corcoran S., Bakiasi G., Tsai L.H., Aubourg P., Ransohoff R.M., et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 2016;22:1358&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5101156</ArticleId><ArticleId IdType="pubmed">27668937</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Peikert K., Gunther R., van der Kooi A.J., Aronica E., Hubers A., Danel V., Corcia P., Pan-Montojo F., Cirak S., et al. Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis. Ann. Clin. Transl Neurol. 2019;6:2384&#x2013;2394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6917314</ArticleId><ArticleId IdType="pubmed">31682085</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya H., Shen M.J., Ichikawa D.M., Sedlock A.B., Choi Y., Johnson K.R., Kim G., Brown M.A., Elkahloun A.G., Maric D., et al. Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. Nat. Neurosci. 2017;20:753&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404968</ArticleId><ArticleId IdType="pubmed">28253233</ArticleId></ArticleIdList></Reference><Reference><Citation>Portz B., Lee B.L., Shorter J. FUS and TDP-43 phases in health and disease. Trends Biochem. Sci. 2021;46:550&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8195841</ArticleId><ArticleId IdType="pubmed">33446423</ArticleId></ArticleIdList></Reference><Reference><Citation>Preuss I., Ludwig M.G., Baumgarten B., Bassilana F., Gessier F., Seuwen K., Sailer A.W. Transcriptional regulation and functional characterization of the oxysterol/EBI2 system in primary human macrophages. Biochem. Biophys. Res. Commun. 2014;446:663&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">24480442</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz M., Jung S., Priller J. Microglia biology: one century of evolving concepts. Cell. 2019;179:292&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">31585077</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustenhoven J., Park T.I., Schweder P., Scotter J., Correia J., Smith A.M., Gibbons H.M., Oldfield R.L., Bergin P.S., Mee E.W., et al. Isolation of highly enriched primary human microglia for functional studies. Sci. Rep. 2016;6:19371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725991</ArticleId><ArticleId IdType="pubmed">26778406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y., Huang E.J. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res. 2016;1647:65&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003642</ArticleId><ArticleId IdType="pubmed">27033831</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza P.V., Pinto W.B., Chieia M.A., Oliveira A.S. Clinical and genetic basis of familial amyotrophic lateral sclerosis. Arq Neuropsiquiatr. 2015;73:1026&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pubmed">26465287</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Luisier R., Taha D.M., Neeves J., Modic M., Mitchell J.S., Meyer I., Greensmith L., Newcombe J., Ule J., et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain. 2019;142:2572&#x2013;2580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Rangaswamy S., Kodavati M., Mitra J., Guo W., Guerrero E.N., Van Den Bosch L., Hegde M.L. RT(2) PCR array screening reveals distinct perturbations in DNA damage response signaling in FUS-associated motor neuron disease. Mol. Brain. 2019;12:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6894127</ArticleId><ArticleId IdType="pubmed">31801573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Szretter K.J., Vermi W., Gilfillan S., Rossini C., Cella M., Barrow A.D., Diamond M.S., Colonna M. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 2012;13:753&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3941469</ArticleId><ArticleId IdType="pubmed">22729249</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisheit I., Kroeger J.A., Malik R., Klimmt J., Crusius D., Dannert A., Dichgans M., Paquet D. Detection of deleterious on-target effects after HDR-mediated CRISPR editing. Cell Rep. 2020;31:107689.</Citation><ArticleIdList><ArticleId IdType="pubmed">32460021</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., Jin T., Zhu H., Chen H., Ofengeim D., Zou C., Mifflin L., Pan L., Amin P., Li W., et al. TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell. 2018;174:1477&#x2013;1491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128749</ArticleId><ArticleId IdType="pubmed">30146158</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Zhang J., Kamelgarn M., Niu C., Gal J., Gong W., Zhu H. Subcellular localization and RNAs determine FUS architecture in different cellular compartments. Hum. Mol. Genet. 2015;24:5174&#x2013;5183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643640</ArticleId><ArticleId IdType="pubmed">26123490</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Sloan S.A., Clarke L.E., Caneda C., Plaza C.A., Blumenthal P.D., Vogel H., Steinberg G.K., Edwards M.S., Li G., et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707064</ArticleId><ArticleId IdType="pubmed">26687838</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu S., Liu G., Ozturk A., Hicks G.G. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 2013;9:e1003895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>